Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Sundrug Co ( (JP:9989) ).
Sundrug Co., Ltd. has revised its non-consolidated financial forecasts for the fiscal year ending March 31, 2026, due to increased profits from dividends received from its consolidated subsidiaries. The company’s updated forecast indicates a significant rise in ordinary and net profits, reflecting a strong financial performance that surpasses initial estimates, although it will not affect the consolidated financial forecasts.
The most recent analyst rating on (JP:9989) stock is a Hold with a Yen4700.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. operates in the retail industry, primarily focusing on the drugstore business. The company is listed on the Tokyo Stock Exchange and is known for its comprehensive range of pharmaceutical and health-related products.
Average Trading Volume: 291,568
Technical Sentiment Signal: Buy
Current Market Cap: Yen543.1B
See more insights into 9989 stock on TipRanks’ Stock Analysis page.